Feature | June 20, 2012

Role of Echocardiography in TAVR to be Demonstrated Live at ASE 2012

An angiographic image showing a transesophogeal Echo (TEE) probe in use during deployment of a transcatheter Sapien aortic valve.

June 20, 2012 — Echocardiography is playing a key role in both the assessment and guidance of transcatheter aortic valve replacement (TAVR). Attendees at the American Society of Echocardiography’s 23rd Annual Scientific Sessions will have the opportunity to see this in action during a live TAVR procedure transmitted from Washington Hospital Center's hybrid cath lab.

The value of TAVR depends on careful selection of patients who, while not surgical candidates, do not have such extreme comorbidities that overwhelm the benefits of TAVR and render the intervention futile. In selection of these patients, Doppler echocardiography has now replaced cardiac catheterization as the gold standard diagnostic technique for quantifying aortic stenosis (AS), the most common valvular heart condition in the elderly. A transthoracic echocardiogram (TTE), in which an external probe is placed on the patient’s chest, can determine whether the AS is severe enough for TAVR. Transesophageal echocardiography (TEE), in which an ultrasound probe is passed into the patient’s esophagus, supplements the information from TTE, providing precise measurements of the ring surrounding the aortic valve, critical for selecting the proper size of the implanted valve.  And, the role for echocardiography doesn’t stop with diagnosis and decisions on treatment, as TEE is widely used to guide device placement during the TAVR procedure.

Steven Goldstein, M.D.,  a cardiologist at MedStar Heart Institute, will lead a team of interventional experts during the surgery at the center. Due to the design of the hybrid cath lab at Washington Medical Center, the audience will be able to see information from various monitors, including echo images, fluoroscopic images and pressure tracings. 

For more information: www.asecho.org

 

Related Content

TAVR, medical guidelines, ACC/AHA, optimization, transcatheter aortic valve replacement
News | Heart Valve Technology| January 18, 2017
The American College of Cardiology recently released new guidance for clinicians and hospitals to use in assessing...
Medtronic, CoreValve Evolut R 34 mm valve, TAVI, CE Mark, European launch
News | Heart Valve Technology| January 17, 2017
Medtronic plc announced the CE (Conformité Européenne) mark and European launch of the CoreValve Evolut R 34 mm valve...
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
Medtronic, Harmony TPV, transcatheter pulmonary valve, clinical study results, TCT 2016
News | Heart Valve Technology| November 02, 2016
Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
Edwards, Sapien transcatheter heart valve, PARTNER trial, five-year echo data, TCT 2016
News | Heart Valve Technology| November 01, 2016
Edwards Lifesciences Corp. announced new five-year hemodynamic data from the PARTNER Trial demonstrating excellent...
Medtronic, CoreValve Evolut R TAVR system, TCT 2016, FORWARD Study, STS/ACC TVT Registry
News | Heart Valve Technology| October 31, 2016
Medtronic plc presented new positive data from two large registries aimed at evaluating 30-day clinical performance...
Mitralign, Trialign tricuspid repair system, SCOUT I study, 30-day data, TCT 2016
News | Heart Valve Technology| October 28, 2016
Mitralign will present data on its Trialign Tricuspid Repair system at the 2016 Transcatheter Cardiovascular...
Interventional cardiology, cath lab technology, TCT, transcatheter cardiovascular therapeutics
Feature | Cath Lab| October 27, 2016 | Dave Fornell
The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventio
BioTrace Medical Tempo temporary pacing lead, TAVR
Technology | Heart Valve Technology| October 27, 2016
October 27, 2016 — BioTrace Medical Inc. said it received U.S.
Overlay Init